AB
Angiocrine Bioscience, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$2.1Msold at filing
Total offering$3M$900K still open
Investors in the raise16count reported to the SEC
FiledSep 5, 2025first sale Aug 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David L ParkinsonDirector
Jeffrey L PortDirector
John T LomoroExecutive Officer
Paul W FinneganExecutive Officer, Director
John R JaskowiakExecutive Officer
Executive officers, directors and promoters as listed on the Form D.